PMV Pharmaceuticals, Inc. (PMVP)

NASDAQ: PMVP · IEX Real-Time Price · USD

1.690

+0.040 (2.42%)

At close: Jul 26, 2024, 4:00 PM

1.679

-0.011 (-0.65%)

After-hours: Jul 26, 2024, 6:40 PM EDT

PMV Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Selling, General & Admin	22.88	24.25	25.05	21.8	11.01	5.88	Upgrade
Research & Development	53.32	55.89	51.99	36.49	23.93	20.76	Upgrade
Operating Expenses	76.2	80.13	77.04	58.29	34.94	26.64	Upgrade
Operating Income	-76.2	-80.13	-77.04	-58.29	-34.94	-26.64	Upgrade
Interest & Investment Income	11.8	11.17	3.63	0.45	0.65	1.3	Upgrade
Other Non Operating Income (Expenses)	-0.03	0	0.09	0.02	-0.14	-0.01	Upgrade
EBT Excluding Unusual Items	-64.43	-	-	-	-	-	Upgrade
Merger & Restructuring Charges	-0.68	-	-	-	-	-	Upgrade
Pretax Income	-65.1	-68.96	-73.33	-57.82	-34.43	-25.34	Upgrade
Income Tax Expense	0	0	-0.01	0.02	0.01	0.01	Upgrade
Net Income	-65.1	-68.96	-73.32	-57.85	-34.44	-25.35	Upgrade
Net Income to Common	-65.1	-68.96	-73.32	-57.85	-34.44	-25.35	Upgrade
Shares Outstanding (Basic)	49	48	46	45	14	3	Upgrade
Shares Outstanding (Diluted)	49	48	46	45	14	3	Upgrade
Shares Change (YoY)	8.24%	5.31%	1.01%	214.23%	373.26%	0.76%	Upgrade
EPS (Basic)	-1.32	-1.44	-1.61	-1.28	-2.40	-8.35	Upgrade
EPS (Diluted)	-1.32	-1.44	-1.61	-1.28	-2.40	-8.35	Upgrade
Free Cash Flow	-58.23	-56.62	-71.74	-47.92	-32.89	-22.17	Upgrade
Free Cash Flow Per Share	-1.18	-1.18	-1.57	-1.06	-2.29	-7.31	Upgrade
EBITDA	-74.75	-78.88	-76.73	-57.99	-34.62	-26.25	Upgrade
D&A For EBITDA	1.45	1.26	0.32	0.31	0.32	0.39	Upgrade
EBIT	-76.2	-80.13	-77.04	-58.29	-34.94	-26.64	Upgrade

Source: S&P Capital IQ. Standard template.